The more sophisticated market participants work the downside. That’s where the biggest (and fastest) money is made.
Trading books and specifically Reminisces of a Stock Operator, (first published in 1923) detail how the wealthiest traders in the world prefer downside action.
The markets are now stretched to obscene levels and could go higher, still.
Just this past week, we have interest rates breaking out to the up-side, a-la August, 1987.
Being long anything other than corn or wheat and the occasional down-trodden coal miner, seems to be a high risk plan (not a recommendation).
Positioning for the downside in the appropriate market, might be a lower risk option than riding the insanity to the top … wherever that is.
Which brings us to inverse biotech fund, BIS. The daily chart shows the well-heeled know something’s up.
Speculative volume for potential downside in biotech is increasing. Last Friday’s volume in BIS was the highest in nearly four years.
BIS was trading higher throughout the entire session until the last few minutes. It closed slightly lower for the day and thus colored the volume bar red.
That minor BIS downturn (up turn in IBB) can be traced directly to Amgen (AMGN) which is now part of the Dow 30, effective Monday the 31st.
It’s important to note that for the past four months, volume activity in IBB has remained relatively unchanged. Not so with BIS.
We’re nearing the Labor Day Weekend during the next sessions. The market will be closed on Monday, September 7th.
Back in the day of 1929, the market made its all time high on September 3rd, the Tuesday after the Labor Day Weekend.
Charts by StockCharts